Go Pro

LENZ Therapeutics (LENZ) Institutional Ownership

LENZ Therapeutics logo
$5.30 -0.46 (-7.99%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$5.41 +0.11 (+2.15%)
As of 07/31/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)

Current
Institutional Ownership
Percentage
54.32%
Number of
Institutional Buyers
(last 12 months)
125
Total
Institutional Inflows
(last 12 months)
$462.80M
Number of
Institutional Sellers
(last 12 months)
23
Total
Institutional Outflows
(last 12 months)
$55.45M
Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE547,534$5.01M0.0%+377.4%1.746%
5/18/2026Royal Bank of Canada95,235$870K0.0%+120.6%0.304%
5/16/2026Quantinno Capital Management LP47,648$436K0.0%N/A0.152%
5/15/2026Affinity Asset Advisors LLC100,000$915K0.0%-200.0%0.319%
5/14/2026Knott David M Jr33,732$309K0.2%-37.2%0.108%
5/7/2026Dimensional Fund Advisors LP41,874$381K0.0%-63.0%0.134%
5/7/2026KBC Group NV90,425$827K0.0%N/A0.288%
5/6/2026C WorldWide Group Holding A S700,000$6.41M0.1%+40.0%2.233%
5/5/2026Bank of New York Mellon Corp49,797$456K0.0%+13.0%0.159%
4/30/2026Hsbc Holdings PLC21,894$204K0.0%N/A0.070%
4/27/2026 Y Intercept Hong Kong Ltd158,715$1.45M0.0%+290.8%0.506%
4/22/2026Janney Montgomery Scott LLC10,814$99K0.0%N/A0.034%
3/17/2026Rockefeller Capital Management L.P.48,071$769K0.0%+167.1%0.154%
3/3/2026Caitong International Asset Management Co. Ltd3,686$59K0.0%N/A0.012%
2/26/2026Aristides Capital LLC10,500$168K0.0%N/A0.034%
2/23/2026Virtu Financial LLC12,347$198K0.0%N/A0.039%
2/19/2026Invesco Ltd.14,046$225K0.0%-96.1%0.045%
2/18/2026XTX Topco Ltd85,782$1.37M0.0%N/A0.274%
2/18/2026VARCOV Co.78,831$1.26M0.5%N/A0.252%
2/18/2026Vestal Point Capital LP275,000$4.40M0.1%N/A0.879%
2/18/2026Virtus Investment Advisers LLC37,674$603K0.2%+879.3%0.120%
2/18/2026Wellington Management Group LLP54,402$870K0.0%-11.3%0.174%
2/18/2026Tang Capital Management LLC865,169$13.84M0.7%-3.6%2.765%
2/18/2026Perceptive Advisors LLC50,000$800K0.0%N/A0.160%
2/18/2026Millennium Management LLC539,348$8.63M0.0%N/A1.724%
2/18/2026Engineers Gate Manager LP31,058$497K0.0%N/A0.099%
2/17/2026Freestone Grove Partners LP22,971$368K0.0%N/A0.073%
2/17/2026Trexquant Investment LP173,183$2.77M0.0%N/A0.553%
2/17/2026Jump Financial LLC40,851$654K0.0%N/A0.131%
2/17/2026Price T Rowe Associates Inc. MD1,023,542$16.38M0.0%+307.6%3.271%
2/17/2026Rock Springs Capital Management LP257,460$4.12M0.2%+9.0%0.823%
2/17/2026Russell Investments Group Ltd.15,461$247K0.0%-89.3%0.049%
2/17/2026Granahan Investment Management LLC431,100$6.90M0.3%+125.2%1.378%
2/17/2026State of Wisconsin Investment Board32,235$516K0.0%+33.7%0.103%
2/17/2026ExodusPoint Capital Management LP23,147$370K0.0%N/A0.074%
2/17/2026Royal Bank of Canada43,172$691K0.0%-10.6%0.138%
2/17/2026Blair William & Co. IL10,207$163K0.0%+27.7%0.033%
2/16/2026Squarepoint Ops LLC491,898$7.87M0.0%+447.8%1.572%
2/16/2026Verition Fund Management LLC46,268$740K0.0%N/A0.148%
2/16/2026Entropy Technologies LP11,000$176K0.0%N/A0.035%
One signature away. Expected within months. (Ad)

On May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on American soil. Congress had 25 days notice and raised no objections. The company's own filings cite substantial support and partnership from the Department of War. Alongside gold, the deposit holds a second metal China has banned from export to the U.S., the only domestic reserve of its kind. The company is roughly one fiftieth the size of Newmont.tc pixel

Get the name and ticker before the signature is finalized
2/16/2026Barclays PLC72,432$1.16M0.0%+51.4%0.231%
2/13/2026Marshall Wace LLP35,252$564K0.0%N/A0.113%
2/13/2026AWM Investment Company Inc.150,000$2.40M0.2%N/A0.479%
2/13/2026Jacobs Levy Equity Management Inc.270,919$4.34M0.0%N/A0.866%
2/13/2026Vivaldi Capital Management LP64,052$1.03M0.1%+23.8%0.205%
2/13/2026Alyeska Investment Group L.P.463,495$7.42M0.0%+91.4%1.481%
2/13/2026Charles Schwab Investment Management Inc.169,122$2.71M0.0%+5.4%0.540%
2/13/2026State Street Corp510,749$8.17M0.0%+22.2%1.632%
2/13/2026Caitong International Asset Management Co. Ltd1,988$32K0.1%N/A0.006%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC18,851$302K0.0%+61.2%0.060%
2/13/2026Wells Fargo & Company MN22,916$367K0.0%+119.3%0.073%
2/12/2026HRT Financial LP171,283$2.74M0.0%+484.4%0.547%
2/12/2026Aristides Capital LLC10,500$168K0.0%N/A0.034%
2/12/2026Dimensional Fund Advisors LP113,094$1.81M0.0%+176.6%0.361%
2/12/2026Federated Hermes Inc.62,636$1.00M0.0%N/A0.200%
2/12/2026Marex Group plc16,000$256K0.0%N/A0.051%
2/12/2026 New York State Common Retirement Fund6,693$107K0.0%+49.0%0.021%
2/12/2026Knott David M Jr53,732$860K0.4%-34.5%0.172%
2/12/2026Nuveen LLC39,905$638K0.0%-86.0%0.128%
2/11/2026Primecap Management Co. CA372,200$5.96M0.0%N/A1.190%
2/11/2026Fox Run Management L.L.C.15,739$252K0.0%N/A0.050%
2/11/2026Franklin Resources Inc.1,096,334$17.54M0.0%+86.7%3.504%
2/11/2026Los Angeles Capital Management LLC3,888$62K0.0%N/A0.012%
2/11/2026Propel Bio Management LLC59,085$945K0.8%N/A0.189%
2/11/2026State of Wyoming1,849$30K0.0%N/A0.006%
2/10/2026TD Asset Management Inc26,978$432K0.0%-14.1%0.086%
2/10/2026Goldman Sachs Group Inc.257,942$4.13M0.0%+524.9%0.824%
2/10/2026AXQ Capital LP19,839$317K0.1%+289.2%0.063%
2/10/2026Nomura Asset Management Co. Ltd.96,780$1.55M0.0%+121.1%0.309%
2/9/2026Geode Capital Management LLC461,075$7.38M0.0%+1.4%1.474%
2/9/2026Sectoral Asset Management Inc.42,500$680K0.5%N/A0.136%
2/9/2026Blue Owl Capital Holdings LP150,000$2.40M0.2%N/A0.479%
2/9/2026 Simplify Asset Management Inc.17,481$280K0.0%N/A0.056%
2/5/2026AlphaCore Capital LLC10,000$160K0.0%N/A0.032%
2/5/2026DNB Asset Management AS19,163$307K0.0%N/A0.061%
2/4/2026C WorldWide Group Holding A S500,000$8M0.1%N/A1.598%
1/29/2026UBS Group AG1,571,738$25.15M0.0%+30.8%5.023%
1/29/2026 China Universal Asset Management Co. Ltd.5,099$82K0.0%-36.3%0.016%
1/23/2026 State of Alaska Department of Revenue19,159$306K0.0%N/A0.061%
1/20/2026 Sovran Advisors LLC160,134$2.56M0.2%+49.8%0.512%
1/20/2026Harbor Capital Advisors Inc.23,921$383K0.0%+63.8%0.076%
1/16/2026Aberdeen Group plc489,432$7.83M0.0%+274.4%1.564%
1/1/2026JPMorgan Chase & Co.11,222$523K0.0%+8.3%0.036%
12/15/2025Hudson Bay Capital Management LP67,225$3.13M0.0%+201.3%0.215%
11/18/2025Advisory Services Network LLC6,421$299K0.0%N/A0.021%
11/17/2025Vivaldi Capital Management LP51,752$2.41M0.3%-12.7%0.165%
11/17/2025Dark Forest Capital Management LP10,163$473K0.0%N/A0.032%
11/17/2025Alyeska Investment Group L.P.242,113$11.28M0.0%+11.5%0.774%
11/17/2025Voleon Capital Management LP8,591$400K0.0%N/A0.027%
11/17/2025Summit Partners Public Asset Management LLC323,857$15.09M0.3%+34.9%1.035%
The dollar just broke (Ad)

Bloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this century — and the consequences for your savings and investments could be severe. President Trump has signed executive order 14241 to initiate the first full reset of the American dollar in 50 years. A new monetary anchor is being established — one that's not gold or crypto, but something far more unexpected that Vladimir Putin once called the key to world leadership.tc pixel

Read the full story on what this dollar reset means for your portfolio
11/17/2025Quarry LP577$27K0.0%N/A0.002%
11/17/2025Plustick Management LLC200,000$9.32M3.9%N/A0.639%
11/17/2025Paradigm Biocapital Advisors LP1,073,461$50.00M1.4%-37.5%3.431%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,480$348K0.0%-23.3%0.024%
11/17/2025Granahan Investment Management LLC191,397$8.92M0.4%+4.4%0.612%
11/17/2025First Light Asset Management LLC693,044$32.28M3.0%N/A2.215%
11/17/2025Cinctive Capital Management LP21,062$981K0.0%N/A0.067%
11/17/2025Bank of America Corp DE349,128$16.26M0.0%+413.6%1.116%
11/17/2025Ally Bridge Group NY LLC175,363$8.17M5.0%-48.9%0.560%
11/17/2025Ameriprise Financial Inc.55,673$2.59M0.0%+3.2%0.178%


LENZ Institutional Ownership - Frequently Asked Questions

During the previous two years, 158 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($123.76M), Vanguard Group Inc. ($61.97M), Paradigm Biocapital Advisors LP ($50.00M), Adage Capital Partners GP L.L.C. ($32.91M), First Light Asset Management LLC ($32.28M), Samsara BioCapital LLC ($28.49M), and UBS Group AG ($25.15M).Learn more on LENZ Therapeutics' institutional investors.

54.32% of LENZ Therapeutics' stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings.

Of the 149 institutional investors that purchased LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($2.66M), Paradigm Biocapital Advisors LP ($1.51M), Price T Rowe Associates Inc. MD ($1.15M), Adage Capital Partners GP L.L.C. ($1.12M), Franklin Resources Inc. ($1.09M), Bank of America Corp DE ($782.04K), and C WorldWide Group Holding A S ($700K).

Institutional investors have bought a total of 16,158,528 shares in the last 24 months. This purchase volume represents approximately $462.80M in transactions.

Of the 23 institutional investors that sold LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Paradigm Biocapital Advisors LP ($643.61K), Invesco Ltd. ($350.22K), Nuveen LLC ($245.64K), Ally Bridge Group NY LLC ($167.96K), Russell Investments Group Ltd. ($129.05K), Dimensional Fund Advisors LP ($71.22K), and Knott David M Jr ($48.27K).

Institutional investors have sold a total of 1,797,590 shares in the last 24 months. This volume of shares sold represents approximately $55.45M in transactions.



This page (NASDAQ:LENZ) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners